• 1
    Van Hoek B, de Boer J, Boudjema K, Williams R, Corsmit O, Terpstra O. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Liver Transplant Registry. J Hepatol 1999; 30: 699705.
  • 2
    Robinson PJ, Bellamy MC, Snook M, Pollard S. Emergency subtotal hepatectomy: a new concept for fulminant hepatic failure due to toxic liver injury. Temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success [abstract]. HEPATOLOGY 2004; 40(Suppl 1): 219A.
  • 3
    Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores — where are we and where should we go? J Hepatol 2004; 41: 344350.
  • 4
    O'Grady J, Alexander G, Hayllar K, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439445.
  • 5
    Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced liver failure. Lancet 2002; 359: 558563.
  • 6
    Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver ailure. Evaluation of the London and Clichy criteria. J Hepatol 1993; 17: 124127.
  • 7
    Anand A, Nightingale P, Neuberger J. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997; 26: 6268.
  • 8
    Dabos KJ, Newsome PN, Parkinson JH, Mohammed HH, Sadler IH, Plevris JN, et al. Biochemical prognostic markers of outcome in non-paracetamol induced fulminant hepatic failure. Transplantation 2004; 77: 200205.
  • 9
    Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systemic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003; 31: 299305.
  • 10
    Wiesner RH. MELD/PELD and the allocation of deceased donor livers for recipients with acute fulminant hepatic failure, primary non-function, hepatic artery thrombosis and acute Wilson's disease. Liver Transplantation 2004; 10(Suppl 2): S17S22.
  • 11
    Baquerizo A, Anselmo D, Shackleton C, Chen TW, Cao C, Weaver M, et al. Phosphorus as an early predictive factor in patients with acute liver failure. Transplantation 2003; 75: 20072014.
  • 12
    Murray-Lyon IM, Orr AH, Gazzard B, Kohn J, Williams R. Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. Gut 1976; 17: 576580.
  • 13
    Deasy NP, Wendon J, Meire HB, Sidhu PS. The value of serial Doppler ultrasound as a predictor of clinical outcome and the need for transplantation in acute and sub-acute liver failure. Br J Radiol 1999; 72: 134143.
  • 14
    Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, et al. The role of transjugular liver biopsy in fulminant hepatic failure: relationship to other prognostic indicators. HEPATOLOGY 1993; 18: 13701376.
  • 15
    Schmidt LE, Ott P, Tygstrup N. Galactose elimination capacity as a prognostic marker for severe acetaminophen-induced hepatotoxicity: 10 years' experience. Clin Gastroenterol Hepatol 2004; 2: 418425.
  • 16
    Lee WM, Galbraith RM, Watt GH, Hughes RD, MacIntire DD, Hoffman BJ, et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. HEPATOLOGY 1995; 21: 101105.
  • 17
    Shakil A, Jones B, Lee R, Fung JJ, Rakela J. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 2000; 45: 334339.
  • 18
    Saibara T, Onishi S, Sone J, Yamamoto N, Shimahara Y, Mori K, et al. Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure. Transplantation 1991; 51: 782786.
  • 19
    Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation Factor V and VII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992; 33: 98102.
  • 20
    Bloomer JR, Waldman TA, McIntire KR, Klatskin G. Serum alpha-fetoprotein in patients with massive hepatic necrosis. Gastroenterology 1977; 72: 479492.
  • 21
    Sakurai T, Marusawa H, Satomura S, Nabeshima M, Uemoto S, Tan X, et al. Lens culinaris agglutinin A reactive alpfa fetoprotein as a marker for liver atrophy I fulminant hepatic failure. Hepatol Res 2003; 26: 98105.
  • 22
    Schmidt L, Dalhoff K. Alfa-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. HEPATOLOGY 2005: 41: 2631.
  • 23
    OPTN. Available at: Accessed 4th November 2004.
  • 24
    Barshes N, Lee TC. Risk stratification of patients undergoing orthotopic liver transplantation for fulminant hepatic failure using a simple, novel scoring system [abstract]. HEPATOLOGY 2004; 40(Suppl 1): 260A.
  • 25
    Haydon GH, Hiltunen Y, Murphy N, Gunson B, Collett D, Neuberger J. A new model to maximise the utility of liver allografts in patients with fulminant non-A non-B hepatitis [abstract]. HEPATOLOGY 2004: 40(Suppl 1): 552A.
  • 26
    Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004; 40: 192197.